Leisewitz, A. V., Zimmerman, E. I., Jones, S. Z., Yang, J., & Graves, L. M. (2008). Imatinib-Resistant CML Cells Have Low ENT Activity but Maintain Sensitivity to Gemcitabine.

Leisewitz, Andrea V., Eric I. Zimmerman, Shannon Z. Jones, Jing Yang, and Lee M. Graves. Imatinib-Resistant CML Cells Have Low ENT Activity but Maintain Sensitivity to Gemcitabine. 2008.

Leisewitz, Andrea V., et al. Imatinib-Resistant CML Cells Have Low ENT Activity but Maintain Sensitivity to Gemcitabine. 2008.